Cargando…

Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma

BACKGROUND: An important stage in controlling gene expression is RNA alternative splicing (AS), and aberrant AS can trigger the development and spread of malignancies, including hepatocellular carcinoma (HCC). A crucial component of AS is cleavage and polyadenylation-specific factor 4 (CPSF4), a com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuemaierabola, Anwaier, Guo, Jun, Sun, Lili, Yeerkenbieke, Buerlan, Liu, Fuzhong, Ye, Dilinaer, Zhai, Xiaoyi, Guo, Wenjia, Cao, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590311/ https://www.ncbi.nlm.nih.gov/pubmed/37542549 http://dx.doi.org/10.1007/s00432-023-05178-z

Ejemplares similares

CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression
por: Tan, Sheng, et al.
Publicado: (2021)

Silencing LINC00294 Restores Mitochondrial Function and Inhibits Apoptosis of Glioma Cells under Hypoxia via the miR-21-5p/CASKIN1/cAMP Axis
por: Dong, Xiaogang, et al.
Publicado: (2021)

Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing
por: Sakai, Akihiro, et al.
Publicado: (2020)

CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma
por: Huang, Ying, et al.
Publicado: (2023)

Global analysis of CPSF2-mediated alternative splicing: Integration of global iCLIP and transcriptome profiling data
por: Misra, Ashish, et al.
Publicado: (2015)

Alternative Splicing in Hepatocellular Carcinoma
por: Lee, Seung Eun, et al.
Publicado: (2020)

CPSF30 at the Interface of Alternative Polyadenylation and Cellular Signaling in Plants
por: Chakrabarti, Manohar, et al.
Publicado: (2015)

Molecular details of the CPSF73-CPSF100 C-terminal heterodimer and interaction with Symplekin
por: Thore, Stéphane, et al.
Publicado: (2023)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Comprehensive Network Analysis Reveals Alternative Splicing-Related lncRNAs in Hepatocellular Carcinoma
por: Wang, Junqing, et al.
Publicado: (2020)

m(6)A-induced repression of SIAH1 facilitates alternative splicing of androgen receptor variant 7 by regulating CPSF1
por: Xia, Lei, et al.
Publicado: (2022)

Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Archaeal β-CASP ribonucleases of the aCPSF1 family are orthologs of the eukaryal CPSF-73 factor
por: Phung, Duy Khanh, et al.
Publicado: (2013)

Alternative polyadenylation factor CPSF6 regulates temperature compensation of the mammalian circadian clock
por: Schmal, Christoph, et al.
Publicado: (2023)

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2016)

CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer
por: Binothman, Najat, et al.
Publicado: (2017)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1
por: Vivori, Claudia, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Formation of nuclear CPSF6/CPSF5 biomolecular condensates upon HIV-1 entry into the nucleus is important for productive infection
por: Luchsinger, Charlotte, et al.
Publicado: (2023)

Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
por: Bellini, Valeria, et al.
Publicado: (2020)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

Obesity and Heath-Carter Somatotyping of 3438 Adults in the Xinjiang Uygur Autonomous Region of China by Multivariate Analysis
por: Liu, Xiaoyuan, et al.
Publicado: (2021)

Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression
por: Liu, Yang, et al.
Publicado: (2021)

Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6
por: Jang, Sooin, et al.
Publicado: (2019)

Comprehensive Identification and Alternative Splicing of Microexons in Drosophila
por: Pang, Ting-Lin, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors
por: Jin, Young-Joo, et al.
Publicado: (2019)

Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
por: Yu, Shanshan, et al.
Publicado: (2021)

An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma
por: Xu, Rui-Yao, et al.
Publicado: (2022)

Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4
por: Zhuo, Han, et al.
Publicado: (2022)

Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer
por: Shen, Peiye, et al.
Publicado: (2023)

Comprehensive Profiling of Alternative Splicing and Alternative Polyadenylation during Fruit Ripening in Watermelon (Citrullus lanatus)
por: Yu, Yongtao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t45q4v602oli4qt5a3t5p9t6s4